Becker's Healthcare April 29, 2024
Paige Twenter

Pfizer’s first FDA-approved gene therapy is one of the most expensive medications in the U.S.

On April 26, Beqvez (fidanacogene elaparvovec-dzkt) won approval to treat some adults with moderate-to-severe hemophilia B. The drugmaker set the list price at $3.5 million,...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, FDA, Govt Agencies, Pharma / Biotech
How the FDA Lets Chemicals Pour Into America’s Food Supply
Opinion: STAT+: How will the Center for Biologics Evaluation and Research change under RFK Jr.?
FDA OKs First Gene Therapy Implant for a Rare Eye Disease
Gene Therapy in an Implant: Neurotech Lands First FDA Approval in Rare Vision Disorder
FDA nominee pitches AI application review

Share This Article